Simplification of complex insulin regimens using canagliflozin or liraglutide in patients with well‐controlled type 2 diabetes: A 24‐week randomized controlled trial

AIMS/INTRODUCTION: We investigated the potential use of canagliflozin, in comparison with liraglutide, as an alternative to bolus insulin in patients with well‐controlled type 2 diabetes mellitus receiving multiple daily insulin injection therapy. MATERIALS AND METHODS: In 40 patients, with glycated...

Descripción completa

Detalles Bibliográficos
Autores principales: Ando, Yasuyo, Shigiyama, Fumika, Hirose, Takahisa, Kumashiro, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504902/
https://www.ncbi.nlm.nih.gov/pubmed/33650779
http://dx.doi.org/10.1111/jdi.13533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504902/
https://www.ncbi.nlm.nih.gov/pubmed/33650779
http://dx.doi.org/10.1111/jdi.13533

Ejemplares similares